ABUSO DI POSIZIONE DOMINANTE NELLA DISTRIBUZIONE DI GELATI CONFEZIONATI. L’AG RANTOS SI PRONUNCIA SULLA NOZIONE DI “UNITÀ ECONOMICA” E SULL’APPLICABILITÀ GENERALE DELL’AS EFFICIENT COMPETITOR TEST

marketude Consumer Goods, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition

[x_icon type="tag"] EU and Competition, Consumer Goods, Litigation

DE BERTI JACCHIA VINCE AL TRIBUNALE DI SALERNO PER GLAXOSMITHKLINE

marketude

De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. e GlaxoSmithKline Biologicals S.A. davanti al Tribunale di Salerno, in una delicata controversia in tema di responsabilità da prodotto farmaceutico.

CONCENTRAZIONI NEL SETTORE DEL TRASPORTO AEREO. L’AG RANTOS SI PRONUNCIA SUGLI IMPEGNI ASSUNTI DA US AIRWAYS E AMERICAN AIRLINES

marketude Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Transport and Logistic, Litigation

PROPRIETÀ INTELLETTUALE E PIATTAFORME ONLINE. L’AG SZPUNAR SI PRONUNCIA NEL SENSO DELL’IMPOSSIBILITÀ, PER IL TITOLARE DEL MARCHIO, DI VIETARE L’USO DA PARTE DEL GESTORE DI UN MERCATO ONLINE DI UN SEGNO IDENTICO O SIMILE PER PRODOTTI O SERVIZI IDENTICI O SIMILI

marketude EU and Competition, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property

[x_icon type="tag"] EU and Competition, Intellectual Property, Litigation

IL REGOLAMENTO 123/2022 E IL RAFFORZAMENTO DEL MANDATO DELL’EMA

marketude Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

TRATTAMENTO DEI DATI PERSONALI E RAPPRESENTANZA DEGLI INTERESSATI DA PARTE DI UN’ASSOCIAZIONE SENZA SCOPO DI LUCRO. LA DECISIONE DELLA CORTE DI GIUSTIZIA NELLA CAUSA META PLATFORMS

marketude Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity

[x_icon type="tag"] EU and Competition, Data protection and Cybersecurity, Litigation

CANCELLAZIONE DEL VOLO O RITARDO PROLUNGATO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLE NOZIONI DI “VETTORE AEREO OPERATIVO”, DI “PRENOTAZIONE CONFERMATA” E DI “ORARIO DI ARRIVO PREVISTO”

marketude Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Mobility

[x_icon type="tag"] EU and Competition, Mobility, Litigation

DIRETTIVE SELF-EXECUTING, DOVERE DI DISAPPLICAZIONE, GIUDICATO E SOPRAVVENIENZE NORMATIVE. IL CONSIGLIO DI STATO PONE FINE ALLA STORICA PROROGA AUTOMATICA DELLE CONCESSIONI DEMANIALI MARITTIME

marketude Administrative and Public Law, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives

[x_icon type="tag"] Administrative and Public Law, Litigation, Perspectives

LEADERS LEAGUE: RANKED FIRM 2021

marketude Antonella Terranova, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Corporate and Commercial, Guido Callegari, Guido Callegari, Guido Callegari, In the Press, Maria Cristina Franchini, Maria Cristina Franchini, Michelangelo Cicogna

[br]

DE BERTI JACCHIA VINCE PER GLAXOSMITHKLINE SULLA RESPONSABILITÀ DA PRODOTTI FARMACEUTICI

marketude In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press

Sono state pubblicate in rapida successione tre decisioni che hanno definito altrettanti procedimenti giudiziari nei quali De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. ed altre società collegate dell’omonimo gruppo farmaceutico anglosassone, ritenute responsabili di danni – patrimoniali e non – legati all’impiego di propri prodotti.

STUDI LEGALI, UN 2021 NEL SEGNO DELLA RESILIENZA

marketude Agri-Food, Fashion and Luxury, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation

[br]

QUALIFICAZIONE ED AIC DEI MEDICINALI ORFANI. IL TRIBUNALE SI PRONUNCIA SULLA NOZIONE DI “METODO SODDISFACENTE” IN PRESENZA DI UTILIZZI OFF-LABEL DEI MEDICINALI A CONFRONTO

marketude Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation